Atsushi Imaizumi

3.0k total citations
45 papers, 2.4k citations indexed

About

Atsushi Imaizumi is a scholar working on Molecular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Atsushi Imaizumi has authored 45 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Medicine, 17 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Atsushi Imaizumi's work include Curcumin's Biomedical Applications (21 papers), Pharmacological Effects of Medicinal Plants (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Atsushi Imaizumi is often cited by papers focused on Curcumin's Biomedical Applications (21 papers), Pharmacological Effects of Medicinal Plants (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Atsushi Imaizumi collaborates with scholars based in Japan, United States and France. Atsushi Imaizumi's co-authors include Tadashi Hashimoto, Masashi Kanai, Hiroki Sasaki, Shigemi Matsumoto, Tsutomu Chiba, Yoshihiko Otsuka, Hideaki Kakeya, Yoshio Suzuki, Yuji Sato and Koji Hasegawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Atsushi Imaizumi

44 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsushi Imaizumi Japan	24	1.2k	916	411	401	190	45	2.4k
Bharat B. Aggarwal United States	17	591 0.5×	1.2k 1.3×	243 0.6×	227 0.6×	35 0.2×	23	2.6k
Ji Hye Kim United States	11	702 0.6×	1.2k 1.3×	279 0.7×	201 0.5×	33 0.2×	13	2.9k
C. Hu China	30	277 0.2×	2.0k 2.2×	176 0.4×	228 0.6×	78 0.4×	80	3.5k
Sylvie Delhalle Luxembourg	18	559 0.5×	992 1.1×	186 0.5×	180 0.4×	51 0.3×	19	2.0k
Maria Pia Russo Italy	12	627 0.5×	1.0k 1.1×	205 0.5×	172 0.4×	44 0.2×	20	2.5k
Janet L. Funk United States	27	478 0.4×	833 0.9×	261 0.6×	289 0.7×	21 0.1×	88	2.8k
Arun Prasath Lakshmanan Japan	27	342 0.3×	798 0.9×	135 0.3×	295 0.7×	22 0.1×	49	2.0k
Chang-Min Lee South Korea	29	225 0.2×	1.1k 1.2×	159 0.4×	223 0.6×	27 0.1×	60	2.5k
Yong‐Sik Kim South Korea	23	185 0.2×	718 0.8×	123 0.3×	223 0.6×	60 0.3×	53	1.6k
Shobha Ghosh United States	33	245 0.2×	1.7k 1.8×	265 0.6×	625 1.6×	30 0.2×	100	3.8k

Countries citing papers authored by Atsushi Imaizumi

Since Specialization

Citations

This map shows the geographic impact of Atsushi Imaizumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Imaizumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Imaizumi more than expected).

Fields of papers citing papers by Atsushi Imaizumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Imaizumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Imaizumi. The network helps show where Atsushi Imaizumi may publish in the future.

Co-authorship network of co-authors of Atsushi Imaizumi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Imaizumi. A scholar is included among the top collaborators of Atsushi Imaizumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Imaizumi. Atsushi Imaizumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kishimoto, Atsuhiro, Maki Komiyama, Hiromichi Wada, et al.. (2024). Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial. Journal of Health Population and Nutrition. 43(1). 93–93. 3 indexed citations

Komiyama, Maki, Yuka Ozaki, Hiromichi Wada, et al.. (2022). Study protocol to determine the effects of highly absorbable oral curcumin on the indicators of cognitive functioning: a double-blind randomised controlled trial. BMJ Open. 12(9). e057936–e057936. 1 indexed citations

Abe, Tomoyuki, Yoshihito Horisawa, Osamu Kikuchi, et al.. (2022). Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin. European Journal of Pharmacology. 935. 175321–175321. 6 indexed citations

Ito, Akira, Atsuhiro Kishimoto, Atsushi Imaizumi, et al.. (2021). Intra-Articular Injections of Curcumin Monoglucuronide TBP1901 Suppresses Articular Cartilage Damage and Regulates Subchondral Bone Alteration in an Osteoarthritis Rat Model. Cartilage. 13(2_suppl). 153S–167S. 14 indexed citations

Morimoto, Tatsuya, Masafumi Funamoto, Yoichi Sunagawa, et al.. (2016). Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD. International Journal of COPD. Volume 11. 2029–2034. 70 indexed citations

Nakayama, Atsuko, Hiroyuki Morita, Tomoko Nakao, et al.. (2015). A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling. PLoS ONE. 10(9). e0137106–e0137106. 25 indexed citations

Imaizumi, Atsushi. (2015). Highly bioavailable curcumin (Theracurmin): its development and clinical application. PharmaNutrition. 3(4). 123–130. 11 indexed citations

Tanabe, Yoko, Seiji Maeda, Nobuhiko Akazawa, et al.. (2015). Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcumin. European Journal of Applied Physiology. 115(9). 1949–1957. 87 indexed citations

Kanai, Masashi, Yoshihiko Otsuka, Kazunori Otsuka, et al.. (2013). A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients. Cancer Chemotherapy and Pharmacology. 71(6). 1521–1530. 157 indexed citations

10.

Kawanishi, Noriaki, Kouki Kato, Masaki Takahashi, et al.. (2013). Curcumin attenuates oxidative stress following downhill running-induced muscle damage. Biochemical and Biophysical Research Communications. 441(3). 573–578. 61 indexed citations

11.

Suzuki, Katsuhiko, Masaki Takahashi, Kaoru Sugama, et al.. (2012). Assessment of antioxidant and anti-inflammatory actions of curcumin by application of novel neutrophil activity measurement system. 41(4). 343–348. 2 indexed citations

12.

Sunagawa, Yoichi, Hiromichi Wada, Hidetoshi Suzuki, et al.. (2012). A Novel Drug Delivery System of Oral Curcumin Markedly Improves Efficacy of Treatment for Heart Failure after Myocardial Infarction in Rats. Biological and Pharmaceutical Bulletin. 35(2). 139–144. 41 indexed citations

13.

Morimoto, Tatsuya, Hiromichi Wada, Yoichi Sunagawa, et al.. (2012). HIGHLY ABSORPTIVE CURCUMIN IMPROVES LEFT VENTRICULAR DIASTOLIC FUNCTION REGARDLESS OF BLOOD PRESSURE IN HYPERTENSIVE PATIENTS. Journal of the American College of Cardiology. 59(13). E987–E987. 4 indexed citations

14.

Kanai, Masashi, Kenichi Yoshimura, Masanori Asada, et al.. (2010). A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemotherapy and Pharmacology. 68(1). 157–164. 316 indexed citations

15.

Nakamura, Takayuki, et al.. (2007). A novel acetyl-CoA carboxylase inhibitor reduces de novo fatty acid synthesis in HepG2 cells and rat primary hepatocytes. Archives of Biochemistry and Biophysics. 468(1). 44–48. 17 indexed citations

16.

Masuda, Kenichi, Takashi Kamimura, Koji Ishii, et al.. (1996). Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli. Protein Engineering Design and Selection. 9(1). 101–106. 22 indexed citations

17.

Sugawara, Keishin, Takayoshi Hamamoto, Kazumi Yokomizo, et al.. (1993). Efficient production of recombinant human factor VIII by co-expression of the heavy and light chains. Protein Engineering Design and Selection. 6(6). 669–674. 17 indexed citations

18.

Renesto, Patricia, Viviane Balloy, Takashi Kamimura, et al.. (1993). Inhibition by recombinant SLPI and half‐SLPI (Asn⁵⁵‐Ala¹⁰⁷) of elastase and cathepsin G activities: consequence for neutrophil‐platelet cooperation. British Journal of Pharmacology. 108(4). 1100–1106. 27 indexed citations

19.

Imaizumi, Atsushi, Jean Lefort, Dominique Leduc, Arielle Lellouch‐Tubiana, & B. Boris Vargaftig. (1992). Pertussis toxin induces bronchopulmonary hyperresponsiveness in guinea-pigs while antagonizing the effects of formyl-L-methionyl-L-leucyl-L-phenylalanine. European Journal of Pharmacology. 212(2-3). 177–186. 4 indexed citations

20.

Imaizumi, Atsushi, et al.. (1984). A new culturing method for production of filamentous hemagglutinin of Bordetella pertussis. Journal of Microbiological Methods. 2(6). 339–347. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact